Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Arthur Pratt
Newcastle Authors
Title
Year
Full text
Dr Ema-Louise Long
Dr James Stanway
Michael White
Nicola Goudie
Julia Phillipson
et al.
Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis
2025
Dr Fiona Rayner
Shaun Hiu
Dr Theophile Bigirumurame
Dr Amy Anderson
Jon Prichard
et al.
Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study
2025
Tegan McTaggart
Dr Jing Xuan Lim
Dr Katie Smith
Bronagh Heaney
Dr David McDonald
et al.
Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease
2025
Dr Faye Cooles
Gemma Vidal Pedrola
Najib Naamane
Dr Arthur Pratt
Dr Ben Barron-Millar
et al.
Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis
2025
Dr Arthur Pratt
Ethnicity-specific patterns of epigenetic age acceleration in rheumatoid arthritis
2025
Dr Arthur Pratt
Immune checkpoint inhibitor-induced inflammatory arthritis
2025
Dr Leher Gumber
Dr Fiona Rayner
Dr Theophile Bigirumurame
Dr Bernard Dyke
Sean Kerrigan
et al.
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis
2025
Dr Josh Bennett
Dr Kieren Hollingsworth
Dr Arthur Pratt
Abbie Degnan
Professor Grainne Gorman
et al.
Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single arm, experimental medicine study
2025
Dr Arthur Pratt
Specific features of immune ageing are detected in the earliest stages in rheumatoid arthritis development
2025
Professor John Isaacs
Dr Arthur Pratt
Professor Christopher Buckley
Dr Faye Cooles
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
2024
Philip Brown
Dr Amy Anderson
Najib Naamane
Dr Dennis Lendrem
Professor John Isaacs
et al.
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis
2024
Anthony McLean
Dr Gary Reynolds
Dr Arthur Pratt
Leveraging Multi-Tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
2024
Dr Abi Gault
Dr Linda Hogarth
Dr Kristian Williams
Professor Alastair Greystoke
Professor Neil Rajan
et al.
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study
2024
Dr Leher Gumber
Dr Opeyemi Agbeleye
Alex Inskip
Ross Fairbairn
Madeleine Still
et al.
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions
2024
Helen Jones
Michelle Bardgett
Dr Arthur Pratt
Patient and public involvement in the design of an international clinical trial: real world experience
2024
1
2
3
4
5
6
7
8